138 related articles for article (PubMed ID: 25907064)
1. Role of folP1 and folP2 Genes in the Action of Sulfamethoxazole and Trimethoprim Against Mycobacteria.
Liu T; Wang B; Guo J; Zhou Y; Julius M; Njire M; Cao Y; Wu T; Liu Z; Wang C; Xu Y; Zhang T
J Microbiol Biotechnol; 2015 Sep; 25(9):1559-67. PubMed ID: 25907064
[TBL] [Abstract][Full Text] [Related]
2. The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosis.
Vilchèze C; Jacobs WR
Antimicrob Agents Chemother; 2012 Oct; 56(10):5142-8. PubMed ID: 22825115
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis reveals that sulfamethoxazole induces oxidative stress in M. tuberculosis.
Sarkar R; Mdladla C; Macingwana L; Pietersen RD; Ngwane AH; Tabb DL; van Helden PD; Wiid I; Baker B
Tuberculosis (Edinb); 2018 Jul; 111():78-85. PubMed ID: 30029919
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
Crider SR; Colby SD
Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
[TBL] [Abstract][Full Text] [Related]
5. Mutations of folC cause increased susceptibility to sulfamethoxazole in Mycobacterium tuberculosis.
Wang R; Li K; Yu J; Deng J; Chen Y
Sci Rep; 2021 Jan; 11(1):1352. PubMed ID: 33446754
[TBL] [Abstract][Full Text] [Related]
6. Lack of activity of sulfamethoxazole and trimethoprim against anaerobic bacteria.
Rosenblatt JE; Stewart PR
Antimicrob Agents Chemother; 1974 Jul; 6(1):93-7. PubMed ID: 15828176
[TBL] [Abstract][Full Text] [Related]
7. [Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin].
Unal S; Aydin M; Akin A
Mikrobiyol Bul; 1988; 22(4):316-21. PubMed ID: 3266971
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis and trimethoprim-sulfamethoxazole.
Forgacs P; Wengenack NL; Hall L; Zimmerman SK; Silverman ML; Roberts GD
Antimicrob Agents Chemother; 2009 Nov; 53(11):4789-93. PubMed ID: 19564358
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of Mycobacterium tuberculosis to sulfamethoxazole, trimethoprim and their combination over a 12 year period in Taiwan.
Huang TS; Kunin CM; Yan BS; Chen YS; Lee SS; Syu W
J Antimicrob Chemother; 2012 Mar; 67(3):633-7. PubMed ID: 22127584
[TBL] [Abstract][Full Text] [Related]
10. Influence of ionizing radiation on the antimicrobial activity of the antibiotics sulfamethoxazole and trimethoprim.
Sági G; Szabacsi K; Szabó L; Homlok R; Kovács K; Mohácsi-Farkas C; Pillai SD; Takács E; Wojnárovits L
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2018 Jul; 53(8):687-693. PubMed ID: 29485359
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria.
Wallace RJ; Wiss K; Bushby MB; Hollowell DC
Rev Infect Dis; 1982; 4(2):326-31. PubMed ID: 7111959
[TBL] [Abstract][Full Text] [Related]
12. Activity of sulfamethoxazole and trimethoprim against Bacteroides fragilis.
Phillips I; Warren C
Antimicrob Agents Chemother; 1976 May; 9(5):736-40. PubMed ID: 949171
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of in vitro sensitivity testing methods of detecting sulphamethoxazole trimethoprim synergy. Correlation with mouse protection assay.
Rawal BD; Cottis L
Arzneimittelforschung; 1980; 30(7):1049-51. PubMed ID: 6998489
[TBL] [Abstract][Full Text] [Related]
14. Serum and saliva concentrations of sulfamethoxazole and trimethoprim in adults and children: relation between saliva concentrations and in vitro activity against nasopharyngeal pathogens.
Kamme C; Melander A; Nilsson NI
Scand J Infect Dis; 1983; 15(1):107-13. PubMed ID: 6342125
[TBL] [Abstract][Full Text] [Related]
15. Expression of Mycobacterium tuberculosis NLPC/p60 family protein Rv0024 induce biofilm formation and resistance against cell wall acting anti-tuberculosis drugs in Mycobacterium smegmatis.
Padhi A; Naik SK; Sengupta S; Ganguli G; Sonawane A
Microbes Infect; 2016 Apr; 18(4):224-36. PubMed ID: 26706821
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
Brown PD; Freeman A; Foxman B
Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
[TBL] [Abstract][Full Text] [Related]
17. Anti-folates potentiate bactericidal effects of other antimicrobial agents.
Li K; Wang XD; Yang SS; Gu J; Deng JY; Zhang XE
J Antibiot (Tokyo); 2017 Mar; 70(3):285-291. PubMed ID: 28074051
[TBL] [Abstract][Full Text] [Related]
18. Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci.
Najjar A; Murray BE
Antimicrob Agents Chemother; 1987 May; 31(5):808-10. PubMed ID: 3111362
[TBL] [Abstract][Full Text] [Related]
19. Sulfamethoxazole enhances the antimycobacterial activity of rifampicin.
Macingwana L; Baker B; Ngwane AH; Harper C; Cotton MF; Hesseling A; Diacon AH; van Helden P; Wiid I
J Antimicrob Chemother; 2012 Dec; 67(12):2908-11. PubMed ID: 22875849
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of some porcine respiratory tract pathogens to aditoprim, trimethoprim, sulfadimethoxine, sulfamethoxazole, and combinations of these agents.
Mengelers MJ; van Klingeren B; van Miert AS
Am J Vet Res; 1990 Nov; 51(11):1860-4. PubMed ID: 2240813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
